Live feed
Filing
SC 13G/A
SC 13G/A0000902219-20-000421·Revance Therapeutics, Inc.
Schedule 13G ownership disclosure
REVANCE THERAPEUTICS INC
Security class unavailable · CUSIP: 761330109
Event date: 2020-07-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,743,700
- Percent of class
- 5.6800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-20-000421
- Form type
- SC 13G/A
- Filer
- Revance Therapeutics, Inc.
- CIK
- CIK 1479290
- Filed
- Aug 10, 2020
- Reporting period
- Jul 31, 2020
- Description
- Schedule 13G beneficial ownership